Taiwan · Delayed Price · Currency is TWD Tanvex BioPharma Statistics
Total Valuation
TPE:6541 has a market cap or net worth of TWD 8.37 billion. The enterprise value is 9.86 billion.
| Market Cap | 8.37B |
| Enterprise Value | 9.86B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:6541 has 264.99 million shares outstanding. The number of shares has increased by 32.96% in one year.
| Current Share Class | 264.99M |
| Shares Outstanding | 264.99M |
| Shares Change (YoY) | +32.96% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 3.78% |
| Float | 108.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.73 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 5.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.47 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.19 |
| Interest Coverage | -28.01 |
Financial Efficiency
Return on equity (ROE) is -29.78% and return on invested capital (ROIC) is -13.26%.
| Return on Equity (ROE) | -29.78% |
| Return on Assets (ROA) | -12.28% |
| Return on Invested Capital (ROIC) | -13.26% |
| Return on Capital Employed (ROCE) | -20.95% |
| Weighted Average Cost of Capital (WACC) | 4.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 4.89 |
Taxes
In the past 12 months, TPE:6541 has paid 31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.52% in the last 52 weeks. The beta is 0.20, so TPE:6541's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -38.52% |
| 50-Day Moving Average | 37.86 |
| 200-Day Moving Average | 44.74 |
| Relative Strength Index (RSI) | 27.67 |
| Average Volume (20 Days) | 379,632 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6541 had revenue of TWD 657.56 million and -1.47 billion in losses. Loss per share was -5.59.
| Revenue | 657.56M |
| Gross Profit | -898.48M |
| Operating Income | -1.43B |
| Pretax Income | -1.47B |
| Net Income | -1.47B |
| EBITDA | -1.30B |
| EBIT | -1.43B |
| Loss Per Share | -5.59 |
Balance Sheet
The company has 592.56 million in cash and 2.08 billion in debt, with a net cash position of -1.49 billion or -5.63 per share.
| Cash & Cash Equivalents | 592.56M |
| Total Debt | 2.08B |
| Net Cash | -1.49B |
| Net Cash Per Share | -5.63 |
| Equity (Book Value) | 4.97B |
| Book Value Per Share | 18.74 |
| Working Capital | 385.09M |
Cash Flow
In the last 12 months, operating cash flow was -934.97 million and capital expenditures -811.47 million, giving a free cash flow of -1.75 billion.
| Operating Cash Flow | -934.97M |
| Capital Expenditures | -811.47M |
| Depreciation & Amortization | 128.90M |
| Net Borrowing | 435.66M |
| Free Cash Flow | -1.75B |
| FCF Per Share | -6.59 |
Margins
Gross margin is -136.64%, with operating and profit margins of -217.04% and -222.84%.
| Gross Margin | -136.64% |
| Operating Margin | -217.04% |
| Pretax Margin | -222.83% |
| Profit Margin | -222.84% |
| EBITDA Margin | -197.44% |
| EBIT Margin | -217.04% |
| FCF Margin | n/a |
Dividends & Yields
TPE:6541 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.96% |
| Shareholder Yield | -32.96% |
| Earnings Yield | -17.50% |
| FCF Yield | -20.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.
| Last Split Date | Mar 2, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.3335779572 |
Scores
TPE:6541 has an Altman Z-Score of -0.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.65 |
| Piotroski F-Score | 2 |